Typing for Transplant, valued at US$1.0 billion in 2024, is forecasted to grow at a robust CAGR of 6.0 %, reaching US$1.1 billion in 2025 and an impressive US$1.4 billion by 2030. The escalating ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of ...

Thermo Fisher Scientific Inc. (NYSE:TMO), currently trading at $400.48 and near its 52-week low, has announced a significant long-term incentive for its CEO, Marc N. Casper, by granting ...

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe ...

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...